Free Disclosure Statement - District Court of Delaware - Delaware

Case 1 :05-cv-00562-JJF Document 2 Filed 08/03/2005 Page 1 of 1
UNITED STATES DISTRICT COURT
DISTRICT OF DELAWARE
' l'
KING PHARMACEDTICALS, INC., KING
PHARMACEUTICALS RESEARCH AND
DEVELOPMENT, INC., and WYETH
Piaintiffs, i
vs. 1 Civil Action No.
TEVA PHARMACEUTICALS USA, INC.
Defendant.
RULE 7.1 STATEMENT
Plaintiff King Pharmaceuticals Reseatch and Development, Inc. is the wholly owned
subsidiary of plaintiff King Pharmaceuticals, Inc. No publicly traded entity owns rnore than 10%
ofthe shares of King Pharmaceuticals, Inc.
Dated: August 3, 2005 /s/ Paui E. Crawford
Pant E. Crawford (#493)
Patricia Smink Rogowski (#2632)
CONNOLLY BOVE LODGE & HUTZ LLP
P.O. Box 2207
Wilmington, DE 19899
(302) 658—9i41
Attorneys for plaintiffs, King Pharmaceuticals,
Inc. and King Pharmaceuticals Research and
Development, inc.
OfCounse1:
P. Dominic Cerrito
Daniel L. Malone
JONES DAY
222 East 41st Street
New York, NY 10017
(212) 326-3939
Attorneys for plaintiffs, King Pharmaceuticals,
Inc. and King Pnannaceuticais Research and
Development, Inc.